MFG
GILD icon

Menard Financial Group’s Gilead Sciences GILD Stock Holding History

Menard Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$872K Buy
6,905
+5,202
+305% +$685K 0.47% 44
2026
Q1 		$237K Hold
1,703
– – 0.17% 75
2025
Q4 		$209K Buy
+1,703
New +$207K 0.14% 80
2025
Q3 		– Sell
-3,021
Closed -$335K – 90
2025
Q2 		$335K Buy
3,021
+79
+3% +$8.41K 0.2% 77
2025
Q1 		$288K Buy
+2,942
New +$304K 0.19% 88
2020
Q3 		– Sell
-3,120
Closed -$240K – 142
2020
Q2 		$240K Buy
+3,120
New +$239K 0.3% 87

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Menard Financial Group's GILD Position: Q2 2026 in Review

Menard Financial Group increased its Gilead Sciences (GILD) stake by 305% in Q2 2026, buying an estimated $685K and bringing the position to 6,905 shares worth $872K. The position accounts for 0.47% of the portfolio, ranked #44.

Menard Financial Group first reported a position in GILD in Q2 2020 and has held it in 6 quarters since. 2,264 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Menard Financial Group held 6,905 shares of Gilead Sciences worth $872K as of Q2 2026.
  • Menard Financial Group bought 5,202 Gilead Sciences shares in Q2 2026, an estimated $685K.
  • Gilead Sciences made up 0.47% of Menard Financial Group's portfolio in Q2 2026, its #44 holding.
  • Menard Financial Group first reported a position in Gilead Sciences in Q2 2020 and has held it in 6 quarters since.
  • 2,264 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Menard Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.